共 42 条
Design, Synthesis and X-ray Structural Studies of Potent HIV-1 Protease Inhibitors Containing C-4 Substituted Tricyclic Hexahydro-furofuran Derivatives as P2 Ligands
被引:5
|作者:
Ghosh, Arun K.
[1
,2
]
Kovela, Satish
[1
,2
]
Sharma, Ashish
[1
,2
]
Shahabi, Dana
[1
,2
]
Ghosh, Ajay K.
[1
,2
]
Hopkins, Denver R.
[1
,2
]
Yadav, Monika
[1
,2
]
Johnson, Megan E.
[1
,2
]
Agniswamy, Johnson
[3
,4
]
Wang, Yuan-Fang
[3
,4
]
Hattori, Shin-Ichiro
[5
]
Higashi-Kuwata, Nobuyo
[5
]
Aoki, Manabu
[6
,7
]
Amano, Masayuki
[6
,7
]
Weber, Irene T.
[3
,4
]
Mitsuya, Hiroaki
[6
,7
,8
,9
,10
]
机构:
[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
[2] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA
[3] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA
[4] Georgia State Univ, Dept Chem, Mol Basis Dis, Atlanta, GA 30303 USA
[5] Natl Ctr Global Hlth & Med, Dept Refractory Viral Infect, Res Inst, Shinjuku Ku, Tokyo 1628655, Japan
[6] Kumamoto Univ, Sch Med, Dept Hematol, Kumamoto 8608556, Japan
[7] Kumamoto Univ, Sch Med, Dept Infect Dis, Kumamoto 8608556, Japan
[8] NCI, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, Bethesda, MD 20892 USA
[9] Natl Ctr Global Heath & Med, Ctr Clin Sci, Shinjuku Ku, Tokyo 1628655, Japan
[10] Natl Ctr Global Hlth & Med, Dept Refractory Viral Infect, Shinjuku Ku, Tokyo 1628655, Japan
来源:
基金:
美国国家卫生研究院;
关键词:
antiviral agents;
backbone binding;
HIV-1;
protease;
inhibitors;
multidrug-resistance;
BIS-THF MOIETIES;
ANTIRETROVIRAL THERAPY;
CCP4;
SUITE;
RESISTANT;
DARUNAVIR;
BINDING;
P2-LIGAND;
SELECTION;
STRATEGY;
BACKBONE;
D O I:
10.1002/cmdc.202200058
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
The design, synthesis, X-ray structural, and biological evaluation of a series of highly potent HIV-1 protease inhibitors are reported herein. These inhibitors incorporate novel cyclohexane-fused tricyclic bis-tetrahydrofuran as P2 ligands in combination with a variety of P1 and P2 ' ligands. The inhibitor with a difluoromethylphenyl P1 ligand and a cyclopropylaminobenzothiazole P2 ' ligand exhibited the most potent antiviral activity. Also, it maintained potent antiviral activity against a panel of highly multidrug-resistant HIV-1 variants. The corresponding inhibitor with an enantiomeric ligand was significantly less potent in these antiviral assays. The new P2 ligands were synthesized in optically active form using enzymatic desymmetrization of meso-diols as the key step. To obtain molecular insight, two high-resolution X-ray structures of inhibitor-bound HIV-1 protease were determined and structural analyses have been highlighted.
引用
收藏
页数:12
相关论文